Dr. Eunbi Iris Cho is the Associate Director of ADC Formulation Development at Samsung Biologics. She has extensive experience in ADC formulation development, including her doctoral dissertation on the solid-state stability of ADCs. She has an extensive background in drug product, formulation, and lyophilization process development and holds a Ph.D. and a bachelor’s degree in pharmaceutical science from Purdue University in West Lafayette, Indiana. Before joining Samsung Biologics, she was an R&D director at NeuroTobe, where she led two pipelines: an antisense oligonucleotide for Parkinson’s disease and a small-molecule drug for dystonia.